Search

Alexandra E Duverger

from Columbus, OH
Age ~45
Get Report
Also known as:
Alexandra Emilie Duverger
Connected to:
Amy Duverge, 39David J Duverger, 78Fedeline Duverger, 55Joe Duverger, 42Johanne Duverger, 60Kathleen Duverge, 29Laura Duverge, 41Olga D Duverge, 73Pierre C Duverger, 47Stephanie A Duverge, 32

Alexandra Duverger Phones & Addresses

  • Columbus, OH
  • 4904 Indian Valley Rd, Birmingham, AL 35244 (205) 252-2858
  • Vestavia, AL

Work

Company: University of alabama at birmingham Sep 2008 Position: Post-doctoral fellow

Education

Degree: Doctorat School / High School: Ecole doctorale ABIES 2003 to 2007 Specialities: Immunology

Skills

Multi Color Flow Cytometry • Elisa • Mammalian Cell Culture • Science • Molecular Biology • Transient Transfection • Primary Cell Isolation • Pcr • In Vitro • Cell Culture • Research • Elispot • Luminex • Biosafety Level 2 Plus Training • Genetics • Cell Biology • Handling of Small Laboratory Animals • Western Blotting

Languages

French • English • German • Spanish

Industries

Higher Education

Resumes

Resumes

Alexandra Duverger Photo 1

Scientist I

View page
Location:
Fishers, IN
Industry:
Higher Education
Work:
University of Alabama at Birmingham since Sep 2008
Post-doctoral fellow
The Ohio State University May 2006 - Dec 2007
Research Assistant
University of Alabama at Birmingham Sep 2003 - Jun 2006
Visiting Scientist
Education:
Ecole doctorale ABIES 2003 - 2007
Doctorat, Immunology AgroParisTech - Institut des sciences et industries du vivant et de l'environnement 1998 - 2002
Master, Nutrition and Food Science Lycée du Parc, Lyon 1996 - 1998
Skills:
Multi Color Flow Cytometry
Elisa
Mammalian Cell Culture
Science
Molecular Biology
Transient Transfection
Primary Cell Isolation
Pcr
In Vitro
Cell Culture
Research
Elispot
Luminex
Biosafety Level 2 Plus Training
Genetics
Cell Biology
Handling of Small Laboratory Animals
Western Blotting
Languages:
French
English
German
Spanish

Publications

Us Patents

Latent Human Immunodeficiency Virus Reactiviation

View page
US Patent:
20130096054, Apr 18, 2013
Filed:
May 18, 2011
Appl. No.:
13/698490
Inventors:
Olaf Kutsch - Birmingham AL, US
Michael Niederweis - Homewood AL, US
Frank Wolschendorf - Birmingham AL, US
Alexandra Duverger - Birmingham AL, US
Frederic Wagner - Birmingham AL, US
Assignee:
THE UAB RESEARCH FOUNDATION - Birmingham AL
International Classification:
C07K 14/16
A61K 45/00
A61K 38/16
US Classification:
514 41, 435375, 4352521, 435 691, 530350
Abstract:
Provided herein are methods or reactivating a latent Human Immunodeficiency Virus (HIV) infection in a cell. The methods comprise modulating a level of NF-κB activity in the cell by contacting the cell with an agent that produces a transient first increase in the level of NF-κB activity without a second delayed increase in NF-κB activity. Optionally, a second agent is used to prime the reactivation. Also provided herein is an isolated bacterium or population thereof capable of producing a HIV-1 reactivating factor (HRF). Also provided are methods of culturing the bacteria. Further provided are methods of reactivating a latent Human Immunodeficiency Virus-1 (HIV-1) infection in a subject comprising administering to the subject a HIV-1 reactivating factor produced by bacteria, optionally with a priming agent.

Latent Human Immunodeficiency Virus Reactivation

View page
US Patent:
20150105333, Apr 16, 2015
Filed:
Oct 17, 2014
Appl. No.:
14/517253
Inventors:
- Birmingham AL, US
Michael Niederweis - Homewood AL, US
Frank Wolschendorf - Birmingham AL, US
Alexandra Duverger - Birmingham AL, US
Frederic Wagner - Birmingham AL, US
International Classification:
A61K 38/16
A61K 45/06
A61K 38/08
US Classification:
514 211, 514 212, 435375
Abstract:
Provided herein are methods or reactivating a latent Human Immunodeficiency Virus (HIV) infection in a cell. The methods comprise modulating a level of NF-κB activity in the cell by contacting the cell with an agent that produces a transient first increase in the level of NF-κB activity without a second delayed increase in NF-κB activity. Optionally, a second agent is used to prime the reactivation. Also provided herein is an isolated bacterium or population thereof capable of producing a HIV-1 reactivating factor (HRF). Also provided are methods of culturing the bacteria. Further provided are methods of reactivating a latent Human Immunodeficiency Virus-1 (HIV-1) infection in a subject comprising administering to the subject a HIV-1 reactivating factor produced by bacteria, optionally with a priming agent.
Control profile
Alexandra E Duverger from Columbus, OH, age ~45 Get Report